Prosecution Insights
Last updated: October 02, 2026

Examiner: BOESEN, CHRISTIAN C

Tech Center 1600 • Art Units: 1623 1636 1639 1675 1684

This examiner grants 76% of resolved cases

Analysis

Christian C. Boesen is a patent examiner in Tech Center 1600, assigned to Art Unit 1623. He has managed 643 resolved cases, providing a substantial amount of data for analysis. The allowance rate pct for Boesen is 75.9, which indicates a high frequency of patent grants. This 75.9 allowance rate pct suggests that practitioners have a strong probability of success when navigating the examination process in Art Unit 1623.

The median days to allowance is 1321, representing the typical timeframe for successful applications. Boesen also demonstrates an interview lift pct of 21.1, which shows that conducting an interview can provide a significant improvement in the chances of allowance. While the 75.9 allowance rate pct is already high, the 21.1 interview lift pct indicates that verbal advocacy is a very useful strategy for resolving outstanding issues. With 643 resolved cases and a 1321 median days to allowance, Boesen maintains a steady pace of resolutions within Tech Center 1600.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

75.9%
Allow Rate
+15.9% vs TC avg
659
Total Applications
+21.1%
Interview Lift
1321
Avg Prosecution Days
Based on 643 resolved cases, 2023–2026

Rejection Statute Breakdown

8.6%
§101 Eligibility
17.4%
§102 Novelty
30.1%
§103 Obviousness
25.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17965363 Method for Enriching Extracellular Vesicles From Biological Fluid Samples Non-Final OA Genentech Inc.
17932885 SYSTEMS AND METHODS TO TRACK THE EVOLUTION OF SINGLE CELLS Non-Final OA Genentech, Inc.
18056970 METHODS, SYSTEMS AND KITS FOR POLYPEPTIDE PROCESSING AND ANALYSIS Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18215555 Immuno-PETE Non-Final OA Roche Sequencing Solutions, Inc.
18051966 METHODS AND COMPOSITIONS FOR PREPARING NUCLEIC ACID LIBRARIES Non-Final OA Illumina, Inc.
17938428 COMPOSITIONS AND METHODS OF USING TRANSFER RNAS (tRNAS) Non-Final OA Thomas Jefferson University
17996457 METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE Non-Final OA UNIVERSITÄT ULM
18174086 RECOMBINANT PEPTIDE-MHC COMPLEX BINDING PROTEINS AND THEIR GENERATION AND USE Non-Final OA MOLECULAR PARTNERS AG
17996195 METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT TARGET SEQUENCING IN SINGLE CELLS Non-Final OA SINGLERON (NANJING) BIOTECHNOLOGIES, LTD.
17639818 METHOD FOR ULTRA-RAPIDLY SELECTING SIGNAL PEPTIDE TO WHICH INDIVIDUAL BARCODE SYSTEM FOR INCREASING PROTEIN PRODUCTIVITY IS INTRODUCED Non-Final OA Sung Sub KIM

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month